← Leaderboards
Robert Gerald Whalen
Maxygen, Inc.
$14,419,339
Attributed
$14,717,927
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$25,837,225 · 17
By mechanism
P01$14,152,840 · 2
R43$8,865,583 · 14
R01$2,818,802 · 1
Top collaborators
- Ilhem Messaoudi2 shared
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesAntigensImmunogenicityVirusProteinsImmunizationVariantBaseInfectionSmall Business Innovation Research GrantEpitopesViralNeutralizing AntibodyAntibodiesLifeDirected Molecular EvolutionImmunogenicMonoclonal AntibodiesStructureIn VitroVaccine CandidateVirus-Like ParticleCessation Of LifeHiv-1
Grant awards (43)
Development of a Universal Influenza B Vaccine$300,000
R43 · FY2016 · AI · contact PI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-$828,847
R01 · FY2015 · AI · contact PI
Development of a Universal Influenza B Vaccine$300,000
R43 · FY2015 · AI · contact PI
Novel Subunit Vaccines against Varicella Zoster Virus$297,176
R43 · FY2015 · AI · contact PI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-$840,676
R01 · FY2014 · AI · contact PI
Novel Subunit Vaccines against Varicella Zoster Virus$300,000
R43 · FY2014 · AI · contact PI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-$551,463
R01 · FY2013 · AI · contact PI
Novel Therapeutic Vaccines for Chronic HBV$300,000
R43 · FY2013 · AI · contact PI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-$300,000
R43 · FY2013 · AI · contact PI
Novel Tetravalent Vaccines for Dengue Virus$298,472
R43 · FY2013 · AI · contact PI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-$597,816
R01 · FY2012 · AI · contact PI
Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-$300,000
R43 · FY2012 · AI · contact PI
Novel Therapeutic Vaccines for Chronic HBV$300,000
R43 · FY2012 · AI · contact PI
Novel Tetravalent Vaccines for Dengue Virus$300,000
R43 · FY2012 · AI · contact PI
Improved Vaccines for Influenza B Virus$300,000
R43 · FY2011 · AI · contact PI
VLP-Based Antibody-Inducing Vaccines for HIV-1$299,928
R43 · FY2011 · AI · contact PI
Designing Improved HIV-1 Envelope Proteins as Vaccine Candidates$299,314
R43 · FY2011 · AI · contact PI
Designing Improved HIV-1 Envelope Proteins as Vaccine Candidates$299,760
R43 · FY2010 · AI · contact PI
VLP-Based Antibody-Inducing Vaccines for HIV-1$299,760
R43 · FY2010 · AI · contact PI
Improved Vaccines for Influenza B Virus$298,391
R43 · FY2010 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$1,343,498
P01 · FY2009 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$992,252
P01 · FY2009 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$647,735
P01 · FY2009 · AI · contact PI
Novel Vaccine Immunogens for Pandemic H5 Influenza$300,000
R43 · FY2009 · AI · contact PI
Novel Vaccine Immunogens for Pandemic H5 Influenza$300,000
R43 · FY2009 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$2,725,643
P01 · FY2008 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$781,262
P01 · FY2008 · AI · contact PI
Novel Vaccine Immunogens for Pandemic H5 Influenza$299,983
R43 · FY2008 · AI · contact PI
Novel gp41 Immunogens for HIV-1 Vaccines$298,727
R43 · FY2008 · AI · contact PI
Novel gp41 Immunogens for HIV-1 Vaccines$298,727
R43 · FY2008 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$2,148,589
P01 · FY2007 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$864,291
P01 · FY2007 · AI · contact PI
Vaccines for Eastern and Western Equine Encephalitis Viruses$502,847
R43 · FY2007 · AI · contact PI
Vaccines for Eastern and Western Equine Encephalitis Viruses$502,847
R43 · FY2007 · AI · contact PI
Novel gp41 Immunogens for HIV-1 Vaccines$296,665
R43 · FY2007 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$2,659,826
P01 · FY2006 · AI · contact PI
Vaccines for Eastern and Western Equine Encephalitis Viruses$492,513
R43 · FY2006 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$485,885
P01 · FY2006 · AI · contact PI
Novel HIV-1 Envelope Proteins Based on Consensus Sequences$240,746
R43 · FY2006 · AI · contact PI
Creation of Stable Cleaved Trimers of the HIV-1 Envelope Protein$240,443
R43 · FY2006 · AI · contact PI
Development of Novel Immunogens for Vaccines to HIV-1$1,249,490
P01 · FY2005 · AI
Glycosylation Variants of HIV-1 Envelope$299,284
R43 · FY2005 · AI
Development of Novel Immunogens for Vaccines to HIV-1$254,369
P01 · FY2005 · AI